Clinical trials for Plasmacytoma
7 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07115667Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow InfiltrationInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPhase 2NCT06863584SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II TrialSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE1, PHASE2NCT06429150Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or PlasmacytomaShenzhen Geno-Immune Medical Institute
- RECRUITINGPhase 2NCT05248633Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary PlasmacytomaPeking Union Medical College Hospital
- ACTIVE NOT RECRUITINGPhase 2NCT04174196A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With PlasmacytomaMemorial Sloan Kettering Cancer Center · PI: Urvi Shah, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04166565Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary DiseaseStichting European Myeloma Network
- ACTIVE NOT RECRUITINGPhase 3NCT02544308Trial of Immunomodulatory Therapy in High Risk Solitary Bone PlasmacytomaUniversity College, London · PI: Roger Owen